Cargando…

Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol

AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyanguren, Juana, García‐Garrido, LLuisa, Nebot Margalef, Magdalena, Lekuona, Iñaki, Comin‐Colet, Josep, Manito, Nicolás, Roure, Julia, Ruiz Rodriguez, Pilar, Enjuanes, Cristina, Latorre, Pedro, Torcal Laguna, Jesús, García‐Gutiérrez, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695164/
https://www.ncbi.nlm.nih.gov/pubmed/29154427
http://dx.doi.org/10.1002/ehf2.12152
_version_ 1783280263727415296
author Oyanguren, Juana
García‐Garrido, LLuisa
Nebot Margalef, Magdalena
Lekuona, Iñaki
Comin‐Colet, Josep
Manito, Nicolás
Roure, Julia
Ruiz Rodriguez, Pilar
Enjuanes, Cristina
Latorre, Pedro
Torcal Laguna, Jesús
García‐Gutiérrez, Susana
author_facet Oyanguren, Juana
García‐Garrido, LLuisa
Nebot Margalef, Magdalena
Lekuona, Iñaki
Comin‐Colet, Josep
Manito, Nicolás
Roure, Julia
Ruiz Rodriguez, Pilar
Enjuanes, Cristina
Latorre, Pedro
Torcal Laguna, Jesús
García‐Gutiérrez, Susana
author_sort Oyanguren, Juana
collection PubMed
description AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose dependent, suboptimal doses being common in clinical practice. The 2012 European guidelines recommend close monitoring and dose titration by HF nurses. Our main aim is to compare BB doses achieved by patients after 4 months in intervention (HF nurse‐managed) and control (cardiologist‐managed) groups. Secondary aims include comparing doses of the other aforementioned drugs achieved after 4 months, adverse events, and outcomes at 6 months in the two groups. METHODS: We have designed a multicentre (20 hospitals) non‐inferiority randomized controlled trial, including patients with new‐onset HF, left ventricular ejection fraction ≤40%, and New York Heart Association class II–III, with no contraindications to BBs. We will also conduct qualitative analysis to explore potential barriers to and facilitators of dose titration by HF nurses. In the intervention group, HF nurses will implement titration as prescribed by cardiologists, following a protocol. In controls, cardiologists will both prescribe and titrate doses. The study variables are doses of each of the drugs after 4 months relative to the target dose (%), New York Heart Association class, left ventricular ejection fraction, N‐terminal pro B‐type natriuretic peptide levels, 6 min walk distance, comorbidities, renal function, readmissions, mortality, quality of life, and psychosocial characteristics. CONCLUSIONS: The trial seeks to assess whether titration by HF nurses of drugs recommended in practice guidelines is safe and not inferior to direct management by cardiologists. The results could have an impact on clinical practice.
format Online
Article
Text
id pubmed-5695164
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56951642018-02-14 Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol Oyanguren, Juana García‐Garrido, LLuisa Nebot Margalef, Magdalena Lekuona, Iñaki Comin‐Colet, Josep Manito, Nicolás Roure, Julia Ruiz Rodriguez, Pilar Enjuanes, Cristina Latorre, Pedro Torcal Laguna, Jesús García‐Gutiérrez, Susana ESC Heart Fail Original Research Articles AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose dependent, suboptimal doses being common in clinical practice. The 2012 European guidelines recommend close monitoring and dose titration by HF nurses. Our main aim is to compare BB doses achieved by patients after 4 months in intervention (HF nurse‐managed) and control (cardiologist‐managed) groups. Secondary aims include comparing doses of the other aforementioned drugs achieved after 4 months, adverse events, and outcomes at 6 months in the two groups. METHODS: We have designed a multicentre (20 hospitals) non‐inferiority randomized controlled trial, including patients with new‐onset HF, left ventricular ejection fraction ≤40%, and New York Heart Association class II–III, with no contraindications to BBs. We will also conduct qualitative analysis to explore potential barriers to and facilitators of dose titration by HF nurses. In the intervention group, HF nurses will implement titration as prescribed by cardiologists, following a protocol. In controls, cardiologists will both prescribe and titrate doses. The study variables are doses of each of the drugs after 4 months relative to the target dose (%), New York Heart Association class, left ventricular ejection fraction, N‐terminal pro B‐type natriuretic peptide levels, 6 min walk distance, comorbidities, renal function, readmissions, mortality, quality of life, and psychosocial characteristics. CONCLUSIONS: The trial seeks to assess whether titration by HF nurses of drugs recommended in practice guidelines is safe and not inferior to direct management by cardiologists. The results could have an impact on clinical practice. John Wiley and Sons Inc. 2017-04-03 /pmc/articles/PMC5695164/ /pubmed/29154427 http://dx.doi.org/10.1002/ehf2.12152 Text en © 2017 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Oyanguren, Juana
García‐Garrido, LLuisa
Nebot Margalef, Magdalena
Lekuona, Iñaki
Comin‐Colet, Josep
Manito, Nicolás
Roure, Julia
Ruiz Rodriguez, Pilar
Enjuanes, Cristina
Latorre, Pedro
Torcal Laguna, Jesús
García‐Gutiérrez, Susana
Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title_full Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title_fullStr Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title_full_unstemmed Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title_short Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
title_sort design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. etific study protocol
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695164/
https://www.ncbi.nlm.nih.gov/pubmed/29154427
http://dx.doi.org/10.1002/ehf2.12152
work_keys_str_mv AT oyangurenjuana designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT garciagarridolluisa designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT nebotmargalefmagdalena designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT lekuonainaki designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT comincoletjosep designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT manitonicolas designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT rourejulia designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT ruizrodriguezpilar designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT enjuanescristina designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT latorrepedro designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT torcallagunajesus designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT garciagutierrezsusana designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol
AT designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol